Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Precision Sensorimotor Neurorehabilitation Through Personalized Stimulation Loops [NA]
University of Zurich is conducting a clinical trial on precision sensorimotor neurorehabilitation using personalized stimulation loops for P…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable Suspension [Phase 1]
Phase 1 study of HNC364 Injectable Suspension in Parkinson's disease has completed; no detailed results are provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fluctuations [Phase 2]
A Phase 2 clinical trial evaluating the pharmacokinetics, pharmacodynamics, efficacy, and safety of HRG2010 in Parkinson's disease patients …
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: High-Intensity Respiratory Muscle Training in Individuals With Parkinson's Disease [NA]
A clinical trial assessing high-intensity respiratory muscle training in individuals with Parkinson's disease has completed.
-
FDA approval · 2024-09-26FDA Approved: AMANTADINE HYDROCHLORIDE — Original Application (Zhejiang Jutai Pharmaceutical Co., Ltd.)
The FDA approved an original ANDA for amantadine hydrochloride from Zhejiang Jutai Pharmaceutical Co., Ltd., providing a generic version of …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease [Phase 2]
Phase 2 clinical trial exploring a novel therapeutic target to reduce dementia risk in Parkinson disease; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Dopaminergic RestauratIon by IntraVEntriculaire Administration [Phase 1, Phase 2]
Clinical trial update on intraventricular administration for dopaminergic restoration in Parkinson's disease (Phase 1/2), status completed.
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Cilostazol in Parkinson's Disease [Phase 2]
Phase 2 clinical trial investigating cilostazol for Parkinson's disease, sponsored by Ain Shams University, is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Parkinson Disease: A Model of National Digital Interventions to Prevent or Slow a Rise of Non-Communicable
An active-not-recruiting clinical trial examining a model of national digital interventions to prevent or slow the rise of non-communicable …
-
EMA approval · 2024-09-24EMA Authorised: Entacapone Orion (entacapone) — Orion Corporation
Entacapone Orion has been authorised in the EU for Parkinson's disease; Orion Corporation is the marketing authorisation holder.
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease [Phase 3]
Phase 3 trial evaluating solifenacin therapy for urinary symptoms in Parkinson disease completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea [Phase 4]
Phase 4 clinical trial in South Korea evaluating safinamide mesilate as add-on therapy to levodopa for Parkinson disease with motor fluctuat…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: The Efficacy of Olfactory Training Intervention on Olfactory and Other Non-motor Symptoms in PD [NA]
A clinical trial update describing a planned study to assess whether olfactory training can improve olfactory function. The trial will also …
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: 10,000 Step Club: Community Walking Program for People with Parkinson's Disease [NA]
A clinical trial is recruiting for a community walking program called '10,000 Step Club' designed for people with Parkinson's disease, spons…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: How to Get Started: Identifying the Critical Ingredients to Improve Gait Initiation in Parkinson Disease [NA]
This entry notes a completed clinical trial conducted at the University of North Carolina investigating strategies to improve gait initiatio…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Dual-task Augmented Reality Treatment for Parkinson's Disease [Phase 2]
Phase 2 clinical trial evaluating a dual-task augmented reality treatment for Parkinson's disease has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Cognitive Training in Parkinson Study [NA]
A completed clinical trial evaluating cognitive training in Parkinson disease patients with impaired cognition; results were posted in Septe…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease [Phase 2]
A Phase 2 clinical trial evaluating NLY01 in early Parkinson disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease. [Phase 1]
A Phase 1 study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of RO7486967 in participants with early Parkinson…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
A clinical trial update evaluating progression markers in neurodegenerative diseases, including Parkinson's disease, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Deep Brain Stimulation of the Cuneiform Nucleus for Levodopa-resistant Freezing of Gait in Parkinson's Disease [NA]
The study evaluated deep brain stimulation of the cuneiform nucleus for levodopa-resistant freezing of gait in Parkinson disease; the trial …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Visual Perturbation Training to Reduce Fall Risk in People with Parkinson's Disease [NA]
This ClinicalTrials.gov update reports the completion of a study evaluating visual perturbation training to reduce fall risk in people with …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Factors Associated with Falling in Parkinson's Disease [NA]
This clinical trial update reports on factors associated with falling in Parkinson disease. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Role of Nasal Dysbiosis in Parkinson Disease
A completed clinical trial investigating the role of nasal microbiome imbalance (nasal dysbiosis) in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Motor Learning-based Clinical Pilates Rehabilitation Protocol for Patients with Parkinson's Disease [NA]
A completed clinical trial evaluated a motor learning-based clinical Pilates rehabilitation protocol for patients with Parkinson disease.